TBB BUREAU NEW DELHI, APRIL 29, 2021                     Following widespread criticism of its pricing policy, Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine ‘Covaxin’ it plans to sell to the States to Rs 400 per dose from the earlier Rs 600.            To recall Bharat Biotech sold Covaxin to the central government at Rs ...

Read More »